拉坦诺普罗斯特如何改变了青光眼的治疗方法?
Maria Francesca Cordeiro1,2,3, Stefano Gandolfi4, Konstantin Gugleta5
1Imperial College Healthcare NHS Trust, Western Eye Hospital, London, UK.
Acta ophthalmologica
|June 23, 2023
概括
前列腺素类似物 (PGAs) 现在是首选的玻璃眼治疗由于有效性和每天一次的剂量. 本综述考察了它们对25年来临床实践和结果的影响.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
背景情况:
- 玻璃眼是全球视力障碍和失明的主要原因.
- 局部医疗治疗是许多青光眼患者的主要治疗方法.
- 拉塔诺普罗斯特标志着一种新的作用机制的显著进步.
研究的目的:
- 审查前列腺素类似物 (PGAs) 在青光眼治疗中的作用.
- 评估PGA在拉塔诺普罗斯特药物推出后的25年间的影响.
- 评估PGAs对临床实践结果的影响.
主要方法:
- 关于治疗青光眼的前列腺素类似物研究的文献综述.
- 对临床实践趋势和结果的分析.
- 检查PGAs的疗效,副作用和剂量.
主要成果:
- PGAs已经成为初级开角青光眼的首选治疗方法.
- 关键优势包括疗效,有限的全身副作用和每天服用一次剂量.
- 常见的不良事件是轻度至中度的眼睛/周眼,包括高血压和色素变化.
结论:
- 在过去的25年里,PGA已经彻底改变了青光眼的治疗方法.
- 它们的良好形象支持它们作为一线治疗的持续作用.
- 了解不良事件对于患者管理至关重要.
相关概念视频
Open Angle Glaucoma: Treatment
481
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
481
Angle Closure Glaucoma: Treatment
577
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
577
Glaucoma: Overview
630
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
630
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
221
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
221
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.4K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
895
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
895


